Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sclerotherapy Versus Beta‐blockers for Primary Prophylaxis of Oesophageal Variceal Bleeding in Children and Adolescents With Chronic Liver Disease or Portal Vein Thrombosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis_Edited__no_change_to_conclusions_. Accessed 20 April 2024.
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis_Edited__no_change_to_conclusions_. Accessed April 20, 2024.
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis_Edited__no_change_to_conclusions_
Sclerotherapy Versus Beta‐blockers for Primary Prophylaxis of Oesophageal Variceal Bleeding in Children and Adolescents With Chronic Liver Disease or Portal Vein Thrombosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
ID - 438073
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/Sclerotherapy_versus_beta‐blockers_for_primary_prophylaxis_of_oesophageal_variceal_bleeding_in_children_and_adolescents_with_chronic_liver_disease_or_portal_vein_thrombosis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -